Candel Therapeutics (CADL) Revenue (2020 - 2022)

Candel Therapeutics recorded quarterly Revenue of $31000.0 in Q4 2022, little changed quarter-over-quarter from $31000.0 in Q3 2022, and up 416.67% year-over-year from $6000.0 in Q4 2021.

Candel Therapeutics' Revenue history runs 3 years deep, the most recent figure standing at $31000.0 for Q4 2022.

  • In Q4 2022, Revenue rose 416.67% year-over-year to $31000.0; the TTM figure through Dec 2022 stood at $124000.0 (up 25.25% YoY), while the FY2022 annual figure was $125000.0, up 25.0% from the prior year.
  • Revenue came in at $31000.0 for Q4 2022 at Candel Therapeutics, roughly flat from $31000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $31000.0 in Q2 2020 to a low of $6000.0 in Q4 2021.
  • A 3-year average of $28727.3 and a median of $31000.0 in 2020 frame the typical range for Revenue.
  • Across the five-year window, Revenue tumbled 80.65% in 2021 and soared 416.67% in 2022, its largest moves.
  • Candel Therapeutics' Revenue stood at $31000.0 in 2020, then sank by 80.65% to $6000.0 in 2021, then jumped by 416.67% to $31000.0 in 2022.
  • According to Business Quant data, Revenue over the past three periods registered $31000.0, $31000.0, and $31000.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.17 Bn
10 Candel Therapeutics 449.62 Mn 449.62 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 31,000.00
Sep 30, 2022 31,000.00
Jun 30, 2022 31,000.00
Mar 31, 2022 31,000.00
Dec 31, 2021 6,000.00
Sep 30, 2021 31,000.00
Jun 30, 2021 31,000.00
Mar 31, 2021 31,000.00
Dec 31, 2020 31,000.00
Sep 30, 2020 31,000.00
Jun 30, 2020 31,000.00